GLENMARK PHARMS LTD FDA Approval ANDA 208691

ANDA 208691

GLENMARK PHARMS LTD

FDA Drug Application

Application #208691

Application Sponsors

ANDA 208691GLENMARK PHARMS LTD

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL0.5MG0SIROLIMUSSIROLIMUS
002TABLET;ORAL1MG0SIROLIMUSSIROLIMUS
003TABLET;ORAL2MG0SIROLIMUSSIROLIMUS

FDA Submissions

UNKNOWN; ORIG1AP2020-10-16STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

GLENMARK PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208691
            [companyName] => GLENMARK PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"SIROLIMUS","activeIngredients":"SIROLIMUS","strength":"0.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"SIROLIMUS","activeIngredients":"SIROLIMUS","strength":"1MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"SIROLIMUS","activeIngredients":"SIROLIMUS","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/16\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-10-16
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.